Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immune-based therapies in HIV infection: recent developments

S Emery1, H C Lane

  • 1National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia.

AIDS (London, England)
|January 1, 1996
PubMed
Summary

Immunologic therapies are being explored for human immunodeficiency virus (HIV) disease. Clinical trials are essential to determine if these immune-based strategies can preserve immune function and control HIV replication for effective long-term treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of an antibody to α<sub>4</sub>β<sub>7</sub> in the control of SIVmac239-<i>nef-stop</i> infection.

Science (New York, N.Y.)·2019
Same author

CD4+ levels control the odds of induction of humoral immune responses to tracer doses of therapeutic antibodies.

PloS one·2017
Same author

Tuberculosis specific responses following therapy for TB: Impact of HIV co-infection.

Clinical immunology (Orlando, Fla.)·2015
Same author

A comparison of computational models with and without genotyping for prediction of response to second-line HIV therapy.

HIV medicine·2014
Same author

HIV/IL-2 and EBV-associated lymphoproliferative diseases: cause and effect or coincidence?

HIV medicine·2013
Same author

Computational models can predict response to HIV therapy without a genotype and may reduce treatment failure in different resource-limited settings.

The Journal of antimicrobial chemotherapy·2013

Area of Science:

  • Immunology
  • Virology
  • Clinical Medicine

Background:

  • Various immunologic approaches are under investigation as potential treatments for HIV disease.
  • Understanding the complexities of the immune system's response to HIV is crucial for developing effective therapies.

Purpose of the Study:

  • To evaluate the role of immunologic approaches in the clinical management of HIV disease.
  • To explore how clinical trials of immune-based therapies can further unveil HIV pathogenesis and immune responses.

Main Methods:

  • Clinical trials of immunologic therapies for HIV.
  • Analysis of immune system complexities and responses to HIV within clinical trial settings.
  • Evaluation of viral replication dynamics through antiretroviral drug trials.

Related Experiment Videos

Main Results:

  • Clinical trials provide unique opportunities to study HIV pathogenesis in vivo.
  • Antiretroviral drug trials have elucidated HIV replication dynamics.
  • Ongoing trials are revealing the heterogeneity of immune responses to HIV.

Conclusions:

  • Completion of clinical trials is necessary to establish the role of immunologic approaches in HIV management.
  • Effective HIV treatments require long-term immune function preservation and viral replication control.
  • Immune-based therapies hold significant promise as a component of future HIV treatment strategies.